Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
The Journal of Pathology
|
January 31, 2018
The value of cell-free DNA for molecular pathology
Caitlin M Stewart, Prachi D Kothari, Florent Mouliere, et al.
Blood Advances
|
May 28, 2025
Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer
Ing S Tiong, Tamia Nguyen, Chong C Chua, et al.
Diagnostics (Basel, Switzerland)
|
January 14, 2021
Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late
Maarten J IJzerman, Jasper de Boer, Arun Azad, et al.
Pathology
|
May 26, 2022
Clinical validation and implementation of droplet digital PCR for the detection of BRAF mutations from cell-free DNA
Rainier Arnolda, Kerryn Howlett, Timmy Chan, et al.
Genome Biology
|
October 12, 2023
The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection
Ymke van der Pol, Norbert Moldovan, Jip Ramaker, et al.
Blood
|
January 28, 2017
Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes
Paul Yeh, Michael Dickinson, Sarah Ftouni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2007
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer
Sarah-Jane Dawson, Melanie A Price, Mark A Jenkins, et al.
Nature Communications
|
November 14, 2024
Unravelling mutational signatures with plasma circulating tumour DNA
Sebastian Hollizeck, Ning Wang, Stephen Q Wong, et al.
Molecular Systems Biology
|
February 11, 2026
Genetic barcoding uncovers the clonal makeup of solid and liquid biopsies and their ability to capture intra-tumoral heterogeneity
Antonin Serrano, Tom S Weber, Jean Berthelet, et al.
Annals of Surgery
|
June 23, 2022
Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma
Carlos S Cabalag, Michael Yates, Mariana Benitez Corrales, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
The Journal of Pathology
|
January 31, 2018
The value of cell-free DNA for molecular pathology
Caitlin M Stewart, Prachi D Kothari, Florent Mouliere, et al.
Blood Advances
|
May 28, 2025
Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer
Ing S Tiong, Tamia Nguyen, Chong C Chua, et al.
Diagnostics (Basel, Switzerland)
|
January 14, 2021
Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late
Maarten J IJzerman, Jasper de Boer, Arun Azad, et al.
Pathology
|
May 26, 2022
Clinical validation and implementation of droplet digital PCR for the detection of BRAF mutations from cell-free DNA
Rainier Arnolda, Kerryn Howlett, Timmy Chan, et al.
Genome Biology
|
October 12, 2023
The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection
Ymke van der Pol, Norbert Moldovan, Jip Ramaker, et al.
Blood
|
January 28, 2017
Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes
Paul Yeh, Michael Dickinson, Sarah Ftouni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2007
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer
Sarah-Jane Dawson, Melanie A Price, Mark A Jenkins, et al.
Nature Communications
|
November 14, 2024
Unravelling mutational signatures with plasma circulating tumour DNA
Sebastian Hollizeck, Ning Wang, Stephen Q Wong, et al.
Molecular Systems Biology
|
February 11, 2026
Genetic barcoding uncovers the clonal makeup of solid and liquid biopsies and their ability to capture intra-tumoral heterogeneity
Antonin Serrano, Tom S Weber, Jean Berthelet, et al.
Annals of Surgery
|
June 23, 2022
Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma
Carlos S Cabalag, Michael Yates, Mariana Benitez Corrales, et al.
Page
of 9